TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; AND TO AMEND THE LAW CONCERNING TRANSPARENCY AND ACCOUNTABILITY FOR CERTAIN 340B-COVERED ENTITIES.
Bill would have required 340B drug program participants to disclose how they use federal medication discounts through enhanced transparency and accountability reporting requirements.